The most prevalent CKD-related medication categories were angiotensin converting-enzyme inhibitor (ACEIs)/angiotensin receptor blockers (ARBs) and glucocorticoids, which account for 33.4% and 28.8%, respectively, of the total. The gene discussed is ACE; the disease is chronic kidney disease.